These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24953984)

  • 1. The impact of Aldehyde dehydrogenase 1 expression on prognosis for metastatic colon cancer.
    Fitzgerald TL; Rangan S; Dobbs L; Starr S; Sigounas G
    J Surg Res; 2014 Nov; 192(1):82-9. PubMed ID: 24953984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
    Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
    J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of aldehyde dehydrogenase 1 in colon cancer.
    Hou Y; Liu YY; Zhao XK
    Asian Pac J Trop Med; 2013 Jul; 6(7):574-7. PubMed ID: 23768832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer.
    Zhou L; Yu L; Zhu B; Wu S; Song W; Gong X; Wang D
    BMC Cancer; 2016 Nov; 16(1):876. PubMed ID: 27832750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldehyde dehydrogenase 1 expression is correlated with poor prognosis in breast cancer.
    Yao J; Jin Q; Wang XD; Zhu HJ; Ni QC
    Medicine (Baltimore); 2017 Jun; 96(25):e7171. PubMed ID: 28640095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium.
    Ruscito I; Cacsire Castillo-Tong D; Vergote I; Ignat I; Stanske M; Vanderstichele A; Ganapathi RN; Glajzer J; Kulbe H; Trillsch F; Mustea A; Kreuzinger C; Benedetti Panici P; Gourley C; Gabra H; Kessler M; Sehouli J; Darb-Esfahani S; Braicu EI
    Eur J Cancer; 2017 Jul; 79():214-225. PubMed ID: 28525846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of aldehyde dehydrogenase 1 in invasive primary breast tumors and axillary lymph node metastases is associated with poor clinical prognosis.
    Dong Y; Bi LR; Xu N; Yang HM; Zhang HT; Ding Y; Shi AP; Fan ZM
    Pathol Res Pract; 2013 Sep; 209(9):555-61. PubMed ID: 23916993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldehyde dehydrogenase 1 expression in inflammatory breast cancer as measured by immunohistochemical staining.
    Gong Y; Wang J; Huo L; Wei W; Ueno NT; Woodward WA
    Clin Breast Cancer; 2014 Jun; 14(3):e81-8. PubMed ID: 24461456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TWIST1 and SNAI1 as markers of poor prognosis in human colorectal cancer are associated with the expression of ALDH1 and TGF-β1.
    Kim YH; Kim G; Kwon CI; Kim JW; Park PW; Hahm KB
    Oncol Rep; 2014 Mar; 31(3):1380-8. PubMed ID: 24402192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldehyde dehydrogenase isoform 1 (ALDH1) expression as a predictor of radiosensitivity in laryngeal cancer.
    Martín M; Hinojar A; Cerezo L; García J; Lopez M; Prada J; Marín A; Gamallo C
    Clin Transl Oncol; 2016 Aug; 18(8):825-30. PubMed ID: 26572760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44 and ALDH1 immunoexpression as prognostic indicators of invasion and metastasis in oral squamous cell carcinoma.
    Ortiz RC; Lopes NM; Amôr NG; Ponce JB; Schmerling CK; Lara VS; Moyses RA; Rodini CO
    J Oral Pathol Med; 2018 Sep; 47(8):740-747. PubMed ID: 29791975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Value of Cancer Stem Cell Marker ALDH1 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis.
    Chen J; Xia Q; Jiang B; Chang W; Yuan W; Ma Z; Liu Z; Shu X
    PLoS One; 2015; 10(12):e0145164. PubMed ID: 26682730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aldehyde dehydrogenase 1 (ALDH1) expression is associated with a poor prognosis of bladder cancer.
    Xu N; Shao MM; Zhang HT; Jin MS; Dong Y; Ou RJ; Wang HM; Shi AP
    Cancer Epidemiol; 2015 Jun; 39(3):375-81. PubMed ID: 25843691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldehyde dehydrogenase 1/epidermal growth factor receptor coexpression is characteristic of a highly aggressive, poor-prognosis subgroup of high-grade serous ovarian carcinoma.
    Liebscher CA; Prinzler J; Sinn BV; Budczies J; Denkert C; Noske A; Sehouli J; Braicu EI; Dietel M; Darb-Esfahani S
    Hum Pathol; 2013 Aug; 44(8):1465-71. PubMed ID: 23465277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD133 expression predicts post-operative recurrence in patients with colon cancer with peritoneal metastasis.
    Nagata H; Ishihara S; Kishikawa J; Sonoda H; Murono K; Emoto S; Kaneko M; Sasaki K; Otani K; Nishikawa T; Tanaka T; Kiyomatsu T; Hata K; Kawai K; Nozawa H
    Int J Oncol; 2018 Mar; 52(3):721-732. PubMed ID: 29328371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer stem cell marker ALDH1 expression is associated with lymph node metastasis and poor survival in esophageal squamous cell carcinoma: a study from high incidence area of northern China.
    Wang Y; Zhe H; Gao P; Zhang N; Li G; Qin J
    Dis Esophagus; 2012 Aug; 25(6):560-5. PubMed ID: 22098156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic roles of circulating ALDH1
    Tian S; Xing YN; Xia P
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30305380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Impact of ALDH1 Expression in Transitional Cell Carcinoma of the Renal Pelvis.
    Liu J; Jin J; Yang Y; Han W; Yu W; Shen C; Zhang N; Du P; Zhao Q; Wang S; Tang X
    Anticancer Res; 2015 Sep; 35(9):4829-36. PubMed ID: 26254374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in expression of the cancer stem cell marker aldehyde dehydrogenase 1 among estrogen receptor-positive/human epidermal growth factor receptor type 2-negative breast cancer cases with early, late, and no recurrence.
    Miyoshi Y; Shien T; Ogiya A; Ishida N; Yamazaki K; Horii R; Horimoto Y; Masuda N; Yasojima H; Inao T; Osako T; Takahashi M; Tomioka N; Endo Y; Hosoda M; Doihara H; Miyoshi S; Yamashita H;
    Breast Cancer Res; 2016 Jul; 18(1):73. PubMed ID: 27368476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of aldehyde dehydrogenase 1 and transcription factors in both primary breast cancer and axillary lymph node metastases as a prognostic factor.
    Ito M; Shien T; Omori M; Mizoo T; Iwamoto T; Nogami T; Motoki T; Taira N; Doihara H; Miyoshi S
    Breast Cancer; 2016 May; 23(3):437-44. PubMed ID: 25599843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.